1602
A. Keivanloo et al.
PAPER
1H NMR (500 MHz, DMSO-d6): d = 0.87 (t, J = 7.43 Hz, 3 H, CH3),
1.82 (m, J = 7.31 Hz, 2 H, CH2), 4.65 (t, J = 7.24 Hz, 2 H, CH2),
7.79 (t, J = 7.65 Hz, 1 H, CH), 7.83 (s, 1 H, CH pyrrole), 7.86 (m, 1
H, CH), 8.15 (d, J = 8.52 Hz, 1 H, CH), 8.22 (d, J = 8.50 Hz, 1 H,
CH), 10.24(s, 1 H, CHO).
References
(1) (a) Smits, R. A.; Lim, H. D.; Hanzer, A.; Zuiderveld, O. P.;
Guaita, E.; Adami, M.; Coruzzi, G.; Leurs, R.; de Esch, I. J.
P. J. Med. Chem. 2008, 51, 2457. (b) Rong, F.; Chow, S.;
Yan, S.; Larson, G.; Hong, Z.; Wu, J. Bioorg. Med. Chem.
Lett. 2007, 17, 1663. (c) Gao, H. L.; Yamasaki, E. F.; Chan,
K. K.; Shen, L. L.; Snapka, R. M. Mol. Pharmacol. 2003, 63,
1382. (d) Carta, A.; Loriga, M.; Paglietti, G.; Mattana, A.;
Fiori, P. L.; Mollicotti, P.; Sechi, L.; Anetti, S. Eur. J. Med.
Chem. 2004, 39, 195. (e) Hui, X.; Desrivot, J.; Bories, C.;
Loiseau, P. M.; Franck, X.; Hocquemiller, R.; Figadere, B.
Bioorg. Med. Chem. Lett. 2006, 16, 815.
(2) (a) Campiani, G.; Cappelli, A.; Nacci, V.; Anzini, M.;
Vomero, S.; Hamon, M.; Cagnotto, A.; Fracasso, C.; Uboldi,
C.; Caccia, S.; Consolo, S.; Mennini, T. J. Med. Chem. 1997,
40, 3670. (b) Campiani, G.; Morelli, E.; Gemma, S.; Nacci,
V.; Butini, S.; Hamon, M.; Novellino, E.; Greco, G.;
Cagnotto, A.; Goegan, M.; Cervo, L.; Dalla Valle, F.;
Fracasso, C.; Caccia, S.; Mennini, T. J. Med. Chem. 1999,
42, 4362.
Anal. Calcd for C14H13N3O: C, 70.28; H, 5.48; N, 17.56. Found: C,
69.92; H, 5.34; N, 17.68.
1-Isopropyl-1H-pyrrolo[2,3-b]quinoxaline-2-carbaldehyde (4c)
IR (KBr): 1675 (C=O), 1445, 1090, 775 cm–1.
1H NMR (500 MHz, DMSO-d6): d = 1.71 (d, J = 6.92 Hz, 6 H, 2
CH3), 5.75 (m, J = 7.45 Hz, 1 H, CH), 7.80 (t, J = 7.65 Hz, 1 H,
CH), 7.85 (s, 1 H, CH pyrrole), 7.87 (t, J = 7.67 Hz, 1 H, CH), 8.15
(d, J = 8.5 Hz, 1 H, CH), 8.21 (d, J = 8.5 Hz, 1 H, CH), 10.23 (s, 1
H, CHO).
Anal. Calcd for C14H13N3O: C, 70.28; H, 5.48; N, 17.56. Found: C,
70.58; H, 5.58; N, 17.38.
1-Butyl-1H-pyrrolo[2,3-b]quinoxaline-2-carbaldehyde (4d)
IR (KBr): 1680 (C=O), 1450, 1090, 770 cm–1.
(3) (a) Kreher, R.; Use, G. Tetrahedron Lett. 1978, 19, 4671.
(b) Ames, D. E.; Mitchell, J. C.; Takundwa, C. C. J. Chem.
Res. 1985, 144. (c) Sugita, M.; Mitsuhashi, K. J. Heterocycl.
Chem. 1992, 29, 771. (d) Zhang, X.-C.; Huang, W.-y.
Tetrahedron 1998, 54, 12465. (e) Kobayashi, K.; Matoba,
T.; Irisawa, S.; Matsumoto, T.; Morikawa, O.; Konishi, H.
Chem. Lett. 1998, 551. (f) Kobayashi, K.; Matsumoto, T.;
Irisawa, S.; Yoneda, K.; Morikawa, O.; Konishi, H.
Heterocycles 2001, 55, 973.
1H NMR (500 MHz, DMSO-d6): d = 0.89 (t, J = 7.46 Hz, 3 H, CH3),
1.28 (m, J = 7.61 Hz, 2 H, CH2), 1.78 (m, J = 7.49 Hz, 2 H, CH2),
4.70 (t, J = 7.45 Hz, 2 H, CH2), 7.80 (t, J = 8.31 Hz, 1 H, CH), 7.85
(s, 1 H, CH pyrrole), 7.87 (t, J = 8.92 Hz, 1 H, CH), 8.16 (d, J = 8.61
Hz, 1 H, CH), 8.23 (d, J = 8.11 Hz, 1 H, CH), 10.24 (s, 1 H, CHO).
Anal. Calcd for C15H15N3O: C, 71.12; H, 5.97; N, 16.59. Found: C,
70.71; H, 6.16; N, 16.37.
(4) (a) Sonogashira, K. Comprehensive Organic Synthesis, Vol.
3; Trost, B. M.; Fleming, I., Eds.; Pergamon Press: Oxford,
1991, Chap. 2.4, 521. (b) Bumagin, N. A.; Sukhomlinova,
L. I.; Luzikova, E. V.; Tolstaya, T. P.; Beletskaya, I. P.
Tetrahedron Lett. 1996, 37, 897. (c) Hundertmark, T.;
Littke, A. F.; Buchwald, S. L.; Fu, G. C. Org. Lett. 2000, 2,
1729. (d) Erdelyi, M.; Gogoll, A. J. Org. Chem. 2001, 66,
4165.
(5) (a) Paterson, I.; Davies, R. D. M.; Marquez, R. Angew.
Chem. Int. Ed. 2001, 40, 603. (b) Toyota, M.; Komori, C.;
Ihara, M. J. Org. Chem. 2000, 65, 7110. (c) Ioshimura, F.;
Kawata, S.; Hirama, M. Tetrahedron Lett. 1999, 40, 8281.
(d) Nicolaou, K. C.; Dai, W.-M. Angew. Chem., Int. Ed.
Engl. 1991, 30, 1387.
1-(2-Methylpropyl)-1H-pyrrolo[2,3-b]quinoxaline-2-carbalde-
hyde (4e)
IR (KBr): 1680 (C=O), 1440, 1095, 775 cm–1.
1H NMR (500 MHz, DMSO-d6): d = 0.83 (d, J = 6.63 Hz, 6 H, 2
CH3), 2.20 (m, J = 6.82 Hz, 1 H, CH), 4.50 (d, J = 7.47 Hz, 2 H,
CH2), 7.78 (t, J = 7.34 Hz, 1 H, CH), 7.82 (s, 1 H, CH pyrrole), 7.85
(t, J = 7.43 Hz, 1 H, CH), 8.12 (d, J = 8.54 Hz, 1 H, CH), 8.20 (d,
J = 8.44 Hz, 1 H, CH), 10.25 (s, 1 H, CHO).
Anal. Calcd for C15H15N3O: C, 71.12; H, 5.97; N, 16.59. Found: C,
71.46; H, 5.83; N, 16.78.
1-Methyl-1H-pyrrolo[2,3-b]quinoxaline-2-carbaldehyde (4f)
IR (KBr): 1685 (C=O), 1450, 1090, 770 cm–1.
(6) (a) Heravi, M. M.; Keivanloo, A.; Rahimizadeh, M.;
Bakavoli, M.; Ghassemzadeh, M. Tetrahedron Lett. 2004,
45, 5747. (b) Heravi, M. M.; Kivanloo, A.; Rahimzadeh, M.;
Bakavoli, M.; Ghassemzadeh, M.; Neumüller, B.
Tetrahedron Lett. 2005, 46, 1607. (c) Bakherad, M.;
Isfahani, H. N.; Keivanloo, A.; Doostmohammadi, N.
Tetrahedron Lett. 2008, 49, 3819. (d) Bakherad, M.;
Isfahani, H. N.; Keivanloo, A.; Sang, G. Tetrahedron Lett.
2008, 49, 6188.
1H NMR (500 MHz, DMSO-d6): d = 4.13(s, 3 H, CH3), 7.77 (s, 1 H,
CH pyrrole), 7.78 (t, J = 7.65 Hz, 1 H, CH), 7.86 (t, J = 7.68 Hz, 1
H, CH), 8.15 (d, J = 8.52 Hz, 1 H, CH), 8.21 (d, J = 8.52 Hz, 1 H,
CH), 10.23 (s, 1 H, CHO).
Anal. Calcd for C12H9N3O: C, 68.24; H, 4.29; N, 19.89. Found: C,
67.78; H, 4.47; N, 19.66.
Acknowledgment
(7) (a) Li, J. J. J. Org. Chem. 1999, 64, 8425.
(b) Andreichikov, Yu. S.; Pitirimova, S. G.; Saraeva, R. F.;
Goleneva, A. F. Pharm. Chem. J. (Engl. Transl.) 1979, 13,
1141. (c) Cacchi, S.; Fabrizi, G.; Parisi, L. M.; Bernini, R.
Synlett 2004, 287.
We are grateful to the Research Council of Shahrood University of
Technology for the financial support of this work.
Synthesis 2010, No. 10, 1599–1602 © Thieme Stuttgart · New York